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Abstract
Thymic dendritic cells (DC) delete self-Ag-specific thymocytes, and drive development of FoxP3-
expressing immunoregulatory T cells. Unlike medullary thymic epithelial cells (mTEC), which 
express and present peripheral self-Ag, DC must acquire self-Ag to mediate thymic negative 
selection. One such mechanism entails the transfer of surface MHC-self peptide complexes from 
mTEC to thymic DC. Despite the importance of thymic DC “cross-dressing” in negative selection, 
the factors that regulate the process, and the capacity of different thymic DC subsets to acquire 
MHC and stimulate thymocytes are poorly understood. Here intercellular MHC transfer by thymic 
DC subsets was studied using a MHC-mismatch-based in vitro system. Thymic conventional DC 
(cDC) subsets SIRPα+ and CD8α+ readily acquired MHC class I and II from TEC but 
plasmacytoid DC (pDC) were less efficient. Intercellular MHC transfer was donor cell-specific; 
thymic DC readily acquired MHC from TEC plus thymic or splenic DC, whereas thymic or 
splenic B cells were poor donors. Furthermore DC origin influenced cross-dressing; thymic versus 
splenic DC exhibited an increased capacity to capture TEC-derived MHC, which correlated with 
direct expression of EpCAM by DC. Despite similar capacities to acquire MHC-peptide 
complexes, thymic CD8α+ cDC elicited increased T cell stimulation relative to SIRPα+ cDC. DC 
cross-dressing was cell-contact dependent and unaffected by lipid raft disruption of donor TEC. 
Furthermore, blocking PI3K signaling reduced MHC acquisition by thymic CD8α+ cDC and pDC 
but not SIRPα+ cDC. These findings demonstrate that multiple parameters influence the efficiency 
of and distinct mechanisms drive intercellular MHC transfer by thymic DC subsets.
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INTRODUCTION
T cell central tolerance entails both clonal deletion of thymocytes expressing TCR with 
increased affinity for self-Ag, and development of Foxp3-expressing regulatory CD4+ T 
cells (Foxp3+Treg) in the medulla of the thymus. APC in the thymic medulla play an 
essential role in establishing T cell self-tolerance. Medullary thymic epithelial cells (mTEC) 
and dendritic cells (DC) are the primary APC, although B cells and macrophages are also 
found in the medulla. Mature mTEC express high levels of MHC class I and II, 
costimulatory molecules, and the transcription factor autoimmune regulator (AIRE). AIRE 
drives expression of multiple peripheral self-Ag which are processed and presented by 
mTEC (1–4). AIRE has additional functions including regulation of gene expression of 
various chemokines, which localize DC to the medulla (5), and facilitate interactions 
between mTEC and thymic DC (6). Thymic DC are broadly divided into three subsets: 
CD8α+ conventional DC (cDC), signal regulatory protein α+ (SIRPα+) cDC, and 
plasmacytoid DC (pDC). Noteworthy is that thymic versus peripheral DC exhibit a more 
mature phenotype, suggesting distinct functional properties (7). Unlike mTEC, self-Ag must 
be acquired by thymic DC (8–10). Thymic CD8α+ and SIRPα+ cDC localized next to blood 
vessels at the cortico-medullary junction capture blood borne Ag (11, 12); additionally, 
peripheral SIRPα+ cDC and pDC laden with self-Ag migrate to the thymus and contribute to 
central tolerance (13–15).
Thymic DC also obtain mTEC-expressed self-Ag via intercellular transfer (6, 10, 16). Self-
Ag transfer is thought to expand the pool of presenting APC, and increase the efficiency of 
thymocyte negative selection and/or development of Foxp3+Treg. The latter is particularly 
important since only 1–3% of mTEC express a given self-Ag (17). Engulfment of apoptotic 
mTEC by thymic DC is one process by which intercellular Ag transfer is achieved (10). An 
additional and more direct process involves intercellular transfer of plasma membrane 
containing MHC-peptide complexes (pMHC) from live mTEC to DC (6, 10, 16, 18). This 
process has been referred to as “DC cross-dressing” and is mediated by at least 2 distinct 
mechanisms (reviewed in (19, 20)). The first, trogocytosis or “nibbling”, entails contact-
dependent, intercellular transfer of pMHC embedded in plasma membrane, and occurs 
between lymphocytes and innate effectors in various contexts (21–23). Uptake of pMHC 
containing exosomes released by donor cells is a second mechanism believed to promote DC 
cross-dressing (24, 25). Acquisition of donor cell-derived molecules can modify the function 
of the recipient cell, and in turn the nature of an immune response. Intercellular transfer of 
pMHC by DC was first shown to occur extrathymically, and has been associated with viral-, 
tumor- and alloantigen-specific T cell immunity (24, 26). In bone marrow chimera mice, 
donor-derived thymic DC were found to acquire pMHC from host mTEC in vivo, and 
promote thymic negative selection and Foxp3+Treg development in TCR transgenic mice 
(27).
Despite its importance, the mechanism of intercellular MHC transfer between mTEC and 
thymic DC is poorly understood. A recent study reported that thymic CD8α+ cDC 
preferentially acquire MHC from mTEC in vivo (27). However, whether the differences 
reported between CD8α+ cDC, SIRPα+ cDC and pDC are due to distinct frequencies and/or 
spatial distribution versus intrinsic properties of a given subset are unknown. With this in 
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mind, we investigated intercellular pMHC transfer by thymic DC using an in vitro system of 
MHC mismatched TEC to directly test for DC subset-intrinsic properties. A hierarchy of 
acquisition of pMHC from live TEC and T cell stimulatory capacity was seen between 
thymic cDC versus pDC, and thymic versus splenic DC. Furthermore, selectivity of 
intercellular transfer was evident by the ability of thymic DC to acquire MHC from TEC and 
DC, but not B cells. Moreover, efficient MHC transfer by thymic CD8α+ cDC and pDC, but 
not SIRPα+ cDC was dependent on PI3K signaling. These findings indicate that intercellular 
transfer of MHC by thymic DC is a complex process that is influenced by a number of 
parameters.
MATERIALS AND METHODS
Mice
NOD/LtJ (NOD), BALB/cJ (BALB/c), NOD.Cg-Tg(TcraBDC2.5, TcrbBDC2.5)1Doi/DoiJ 
x NOD.129P2(C)-Tcratm1Mjo/DoiJ (BDC2.5), C57BL/6J (B6) and NOD.129S2(B6)-
Airetm1.1Doi/DoiJ (NOD.AIRE−/−) were purchased from the Jackson Laboratories and 
housed under specific pathogen-free conditions. Both male and female mice 6–8 wks of age 
were used but sex-matched within an experiment. No differences between cells isolated from 
male or female mice were observed for any assay. All animal procedures were approved by 
the Institutional Animal Care and Use Committee at the University of North Carolina at 
Chapel Hill.
Cell isolation
For “bulk” DC isolation, thymi or spleens were harvested, minced and digested for 30 min at 
room temperature with 1 mg/ml collagenase D and 20 μg/ml DNAse I (Roche) in R2 
medium (RPMI 1640, 2% FCS, 10 mM HEPES pH 7.4). Following a 5 min incubation with 
10 mM EDTA, cells were centrifuged through an OptiPrep Axis-Shield gradient (28), and 
DC purified with CD11c microbeads and an AutoMACS separator (Miltenyi Biotec).
To isolate TEC, thymi were digested with 1 mg/ml collagenase D and 20 μg/ml DNAse I in 
R2 at 37°C (3 rounds, 15 min each), 15 min with 1.25 mg/ml collagenase/Dispase (Roche) 
and DNAse I, and 5 min with 10 mM EDTA. Cells were centrifuged through a Percoll (GE 
Healthcare) gradient, and TEC purified via CD45+ cell depletion on an AutoMACS 
separator.
Thymic B and splenic B cells (B220+CD11c−) were FACS sorted or enriched using EasySep 
Mouse B Cell Isolation Kit (Stem Cell Technologies). BDC2.5 CD4+ T cells were isolated 
with a CD4+ T cell isolation kit II (Miltenyi Biotec).
Flow Cytometry
The following mAb were purchased from BD Biosciences, BioLegend, eBioscience, Life 
Technologies, and Cell Signaling Technology: αCD11c (N418), αCD8α (53-6.7), αSIRPα 
(P84), αCD45RA (14.8), αB220 (RA3-6B2), αCD3ε (145-2C11), αCD49b (DX5), αCD19 
(1D3), αerythroid cells (Ter-119), αIAk/g7 (10-3.6), αIEd (14-4-4S), αIAb (KH74), αH2Dd 
(34-2-12), αepithelial cell adhesion molecule (EpCAM, G8.8), αCD45.1 (A20), αCD45.2 
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(104), and αphosphorylated (p) AKTThr308 (D25E6). To label lipid rafts, TEC or B cells 
were incubated with 1 μg/ml cholera toxin B subunit*Alexa Fluor 647 (CTxB, Life 
Technologies) in PBS for 15–30 min, then washed. Cells were Fc receptor blocked using 
2.4G2 mAb prior to staining. Dead cells were excluded using propidium iodide, DAPI, 
7AAD, or LIVE/DEAD dye (Life Technologies). Data were acquired on an LSR II, 
LSRFortessa (BD Biosciences) or CyAN ADP (Beckman Coulter) and analyzed using 
FlowJo (TreeStar Inc.). Sorting of DC subsets was performed on a MoFlo XDP (Beckman 
Coulter) or FACSAria III (BD Biosciences) to a purity >95%. To analyze proliferation, 
purified BDC2.5 CD4+ T cells were labeled with 5 μM CellTrace Violet (CTV; Life 
Technologies).
Intercellular MHC Transfer Assay
To examine intercellular MHC transfer in vitro, cells were isolated from MHC-mismatched 
NOD (H2g7), BALB/c (H2d) or B6 (H2b) mice. DC, and MHC “donor” TEC, DC, or B cells 
were co-cultured for 2–4 h in R10 (RPMI 1640/10% FCS, 4 mM L-glutamine, 1x non-
essential amino acids, 1 mM sodium pyruvate, 100 units/ml penicillin, 100 μg/ml 
streptomycin, 55 μM β-mercaptoethanol, 10 mM HEPES pH7.4) and analyzed via flow 
cytometry. In some experiments, a 0.4 μm TransWell apparatus (Corning) was used. For 
inhibition of PI3K, DC were pretreated with LY294002 (LY29, Cell Signaling) for 30–60 
min prior to the addition of TEC and during the co-culture. To examine pAKTThr308 levels, 
NOD DC were cultured with B6 TEC, and then fixed and permeabilized according to the 
manufacturer’s directions. Lipid raft disruption experiments were performed in Opti-MEM 
(Life Technologies) + 5% delipidized FCS (Gemini Bio-Products). TEC were treated with 
methyl β-cyclodextrin (MβCD) or Nystatin (Sigma-Aldrich) for 15 or 60 min, respectively, 
washed, and cultured with DC as above.
Quantitative RT-PCR
Thymic DC were FACS sorted, RNA isolated using TriZol (Life Technologies), and cDNA 
synthesized using Maxima H Minus Reverse Transcriptase (Thermo Scientific) with an 
oligo(dT)18 primer. qPCR was performed using the Maxima SYBR Green Master Mix 
(Thermo Scientific) and a MyIQ iCycler (Bio-Rad). Cycling conditions consisted of: 95°C, 
10 min and 40 cycles of 95°C, 15 s; 60°C, 30 s; 72°C, 30 s followed by dissociation curve 
analysis. Relative expression of Epcam was assessed by the comparative Ct (ΔΔCt) method 
(29) using Hprt as the endogenous reference and EpCAM− cDC as the calibrator sample. 
The following primers were synthesized by the UNC-CH Nucleic Acids Core Facility for 
qPCR: Epcam Forward, 5′–GCGGCTCAGAGAGACTGTG–3′; Epcam Reverse, 5′–
CCAAGCATTTAGACGCCAGTTT–3′; Hprt Forward, 5′– 
GCTATAAATTCTTTGCTGACCTGCTG–3′; Hprt Reverse, 5′– 
AATTACTTTTATGTCCCCTGTTGACTGG–3′.
RESULTS
Thymic DC acquire MHC class I and II from TEC and DC but not B cells
To study in detail intercellular MHC class I and II transfer and test for thymic DC subset-
specific properties, an in vitro co-culture system relying on MHC-mismatched cells was 
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employed (Fig. 1A). NOD (H2g7) thymic DC were tested for the capacity to capture IEd and 
H2Dd from various types of BALB/c (H2d) APC including TEC, as well as DC and B cells 
from the thymus and spleen. The gating strategy to identify the respective thymic DC 
subsets is depicted in Supplemental Fig. 1. Co-culture with BALB/c TEC resulted in up to 
60% of NOD thymic DC rapidly acquiring MHC (e.g. within 4 h) (Fig. 1B,E). CD8α+ and 
SIRPα+ DC exhibited a similar frequency of IEd+ (~60%) and H2Dd+ (~45%) cells (Fig. 
1B,E). On the other hand, pDC displayed reduced MHC acquisition with ~20% and ~10% 
staining for IEd and H2Dd, respectively (Fig. 1B,E).
A similar pattern of acquisition was observed when BALB/c thymic and splenic DC were 
used as MHC donors, although MHC transfer with splenic DC was less efficient (Fig. 1C,E). 
A trend towards preferential acquisition of MHC class II versus class I from BALB/c thymic 
and splenic DC was observed (Fig. 1C,E), which likely reflected the increased level of IEd 
versus H2Dd by the respective donor cells (Fig. 1F). Strikingly, when BALB/c thymic or 
splenic B cells were tested as MHC donors (Fig. 1F), no significant transfer of IEd or H2Dd 
to NOD thymic DC was observed (Fig. 1D,E). Similarly, only a minimal increase (<8%) in 
IEd+ NOD thymic DC was detected when BALB/c splenic B cells were activated prior by 
αIgM, αCD40 or LPS, and surface expression of IEd increased >5-fold (Supplemental Fig. 
2). Analogous results were obtained when BALB/c thymic DC were assessed for MHC 
acquisition from NOD donor cells (data not shown). These data demonstrate that: i) thymic 
CD8α+ and SIRPα+ cDC but not pDC efficiently acquire MHC class I and II, and ii) 
intercellular MHC transfer is readily achieved with donor TEC, and thymic and splenic DC, 
but not B cells from the thymus and spleen.
Thymic versus splenic DC exhibit enhanced acquisition of TEC MHC, which correlates with 
EpCAM expression
Thymic DC display a more activated phenotype relative to splenic DC (7). With this in 
mind, we tested if differences existed between thymic and splenic NOD DC to acquire 
MHC. The frequency of IEd+ and H2Db+ CD8α+ cDC was slightly increased for thymic 
versus splenic DC, whereas a greater difference was seen among SIRPα+ cDC (Fig. 2A–E). 
However, thymic SIRPα+ and CD8α+ cDC acquired significantly more (up to 2–3-fold) IEd 
and H2Dd based on MFI, compared to the corresponding splenic cDC subsets (Fig. 2C,E).
Analyses identified EpCAM as a key marker reflecting the efficiency of MHC acquisition 
between thymic and splenic DC, as well among the thymic cDC subsets. Both the frequency 
(up to 7-fold) and MFI (up to 10-fold) of EpCAM expression were elevated for the 
respective thymic cDC subsets (Fig. 2F,G). pDC exhibited both a reduced frequency of 
EpCAM+ thymic (and splenic) cells, as well as the MFI of EpCAM compared to cDC (Fig. 
2F,G). Notably, the level of acquired MHC was significantly increased for EpCAM+ thymic 
SIRPα+ and CD8α+ cDC relative to the corresponding EpCAM− thymic cDC subsets (Fig. 
2H).
Earlier work reported that thymic DC acquire EpCAM upon capturing plasma membrane 
from EpCAM+ mTEC (10). Our findings, however, suggested that thymic (and splenic) DC 
actually expressed EpCAM. To confirm this observation, thymic cDC were FACS-sorted 
into EpCAM+ and EpCAM− populations (Fig. 2I) and Epcam mRNA measured via qRT-
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PCR. EpCAM+ cDC expressed ~70-fold more Epcam mRNA compared to EpCAM− cDC 
(Fig. 2J). By comparison, TEC expressed ~3-fold more Epcam mRNA than EpCAM+ cDC 
(Fig. 2J). Together these results demonstrate that acquisition of MHC class I and II from 
TEC is not unique to steady-state thymic DC, although thymic DC are more efficient than 
splenic DC at MHC capture, which in turn correlates with increased EpCAM expression.
A hierarchy exists among cross-dressing thymic DC subsets to stimulate T cells
A key question was whether cross-dressing thymic DC were capable of stimulating T cells 
specific for the transferred pMHC. Isolated NOD TEC were pulsed with the IAg7-restricted 
sBDC mimetic peptide, and co-cultured with BALB/c thymic DC. The total thymic DC 
population was then FACS sorted (Fig. 3A) and tested for stimulation of CTV-labeled, TCR 
transgenic BDC2.5 CD4+ T cells specific for sBDC (Fig. 3B). As expected, robust BDC2.5 
CD4+ T cell proliferation was observed when peptide-pulsed live TEC were directly used as 
APC at a 1:10 TEC to T cell ratio (Fig. 3B). Importantly, sorted DC after co-culture with 
TEC also induced BDC2.5 CD4+ T cell proliferation at a 1:2 DC to T cell ratio, that was 
dependent on the sBDC concentration used to pulse donor TEC (Fig. 3B,C). Therefore the 
cross-dressed DC present functional TEC derived MHC molecules that efficiently induce the 
activation of T cells.
Next, whether the 3 thymic DC subsets exhibited distinct stimulatory capacities following 
cross-dressing was examined. FACS-sorted pDC induced only minimal BDC2.5 CD4+ T cell 
proliferation (Fig. 3D). In contrast, robust of BDC2.5 CD4+ T cell proliferation was 
stimulated by FACS-sorted SIRPα+ and CD8α+ cDC (Fig. 3D). Interestingly, CD8α+ cDC 
were the most potent activators of BDC2.5 CD4+ T cells at both the low and high sBDC 
concentration, promoting increased proliferation compared to SIRPα+ cDC (Fig. 3D). 
BALB/c thymic CD8α+ versus SIRPα+ cDC expressed similar levels of CD80, CD86, and 
CD40 (data not shown), which indicated that differences in proliferation were independent 
of co-stimulatory molecules. Together, these data demonstrate that acquired pMHC 
effectively stimulate T cells, and that a hierarchy for CD4+ T cell stimulation exists among 
the subsets of cross-dressing thymic DC.
MHC transfer requires TEC and thymic DC contact and is independent of lipid raft integrity 
of donor cells
The factors that regulate intercellular MHC transfer between TEC and thymic DC have not 
been determined. Initially, we investigated whether the efficiency of MHC transfer is 
influenced by donor cell lipid rafts, in which MHC class II are preferentially found (30). 
Lipid rafts of BALB/c donor cells were labeled with fluorochrome-conjugated CTxB, and 
MHC acquisition by NOD thymic DC measured. Efficient transfer of both TEC-derived IEd 
and CTxB-labeled lipid rafts to the respective thymic DC subsets was observed (Fig. 4A). 
Interestingly, although MHC acquisition from splenic B cells was limited, lipid raft transfer 
was not; specifically the majority of thymic DC stained positively for CTxB-labeled lipid 
rafts (Fig. 4B), indicating efficient yet restrictive plasma membrane exchange between DC 
and B cells.
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To determine whether TEC lipid raft integrity of donor TEC was necessary for MHC capture 
by thymic DC, lipid rafts were disrupted in BALB/c TEC by MβCD, which removes cell 
membrane cholesterol. No difference in thymic DC acquisition of IEd was seen between 
untreated or MβCD-treated donor TEC (Fig. 4C). Similar results were observed utilizing 
nystatin, which disrupts lipid raft integrity by sequestering cholesterol within the cell 
membrane (Supplemental Fig. 3).
Intercellular transfer of MHC is mediated by either cell contact-dependent trogocytosis or 
uptake of exosomes released by donor cells (20). To distinguish between these 2 
mechanisms, BALB/c TEC labeled with CTxB and NOD thymic SIRPα+ and CD8α+ cDC 
were cultured using a transwell apparatus. Consistent with above results (Fig. 1B,E) ~50% 
of SIRPα+ and CD8α+ cDC acquired IEd upon direct culture with donor TEC (Fig. 4D, 
middle panels). In contrast, no acquisition of IEd and an ~85% MFI reduction in CTxB 
transfer was observed when thymic SIRPα+ and CD8α+ cDC were separated from TEC 
(Fig. 4D, lower panels). Collectively, these results indicate that thymic DC via cell contact 
efficiently acquire MHC and lipid rafts, and that lipid raft integrity of donor TEC is not 
required for efficient intercellular MHC transfer.
Efficiency of MHC acquisition by pDC and CD8α+ cDC but not SIRPa+ cDC is reduced by 
blocking PI3K signaling
Since T cells require PI3K signaling during TCR-mediated trogocytosis (23), we 
hypothesized that this pathway also regulates MHC acquisition by thymic DC. Accordingly, 
phosphorylation of AKT, a conical intermediate in the PI3K signaling pathway was studied. 
NOD thymic DC were co-cultured with B6 TEC, and levels of pAKTThr308 measured by 
flow cytometry. IAb+ pDC, and to a lesser extent IAb+ CD8α+ cDC exhibited elevated levels 
of pAKTThr308 compared to IAb− pDC and CD8α+ cDC, respectively (Fig. 5A,B). In 
contrast, a minimal increase in the level of pAKTThr308 was detected between IAb+ versus 
IAb− SIRPα+ cDC (Fig. 5A,B). Constitutive levels of pAKTThr308, however, were markedly 
greater in SIRPα+ cDC than that detected in both pDC and CD8α+ cDC (Fig. 5A).
The above findings suggested that PI3K signaling was involved in MHC acquisition by 
thymic pDC and CD8α+ cDC but not SIRPα+ cDC. To test this scenario, NOD thymic DC 
were pretreated with the PI3K inhibitor LY29 and the efficiency of IEd transfer from 
BALB/c TEC measured. The frequency of IEd+ SIRPα+ cDC as well as the MFI of captured 
IEd was not significantly affected at the doses of LY29 tested (Fig. 5C–E). In contrast, both 
the frequency of IEd+ cells and the level of acquired MHC class II by pDC and CD8α+ cDC 
were significantly reduced by LY29 treatment (Fig. 5B–D); notably DC viability was 
minimally affected by the different LY29 concentrations tested (data not shown). In sum, 
these results demonstrate that PI3K signaling is necessary for efficient MHC acquisition by 
pDC and CD8α+ cDC, and that SIRPα+ cDC cross-dressing is regulated in a distinct 
manner.
DISCUSSION
Unidirectional transfer of pMHC between mTEC and thymic DC has been reported in vivo, 
and shown to impact thymic negative selection and Foxp3+Treg development (10). The 
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parameters that influence thymic intercellular pMHC transfer, and the acquisition 
capabilities of the respective thymic DC subsets, however, are poorly defined. This study 
provides novel insight into these key issues, demonstrating that: i) thymic DC subsets differ 
in the capacity to acquire MHC and stimulate T cells, ii) the identity of the donor cell type 
influences the efficiency of MHC acquisition by thymic DC, iii) thymic versus splenic DC 
exhibit an enhanced capacity to capture MHC, and iv) distinct mechanisms are utilized for 
MHC acquisition by the thymic DC subsets.
A hierarchy in the efficiency of intercellular MHC transfer was found among thymic DC 
subsets and the corresponding splenic DC subsets. Acquisition of MHC class I and II was 
more efficient for: i) thymic SIRPα+ and CD8α+ cDC compared to thymic pDC (Fig. 1), 
and ii) thymic versus splenic cDC (Fig. 2). Thymic CD8α+ and SIRPα+ cDC acquired MHC 
to the same extent which is in contrast with an earlier study showing preferential acquisition 
by CD8α+ cDC in vivo (27). The ~3-fold increase in the frequency of CD8α+ cDC in the 
adult mouse thymus (Supplemental Fig. 1), however, would be expected to aid MHC uptake 
versus SIRPα+ cDC. Notably, increased EpCAM expression correlated with enhanced 
efficiency of MHC acquisition by the respective DC (Fig. 2). EpCAM has been used as a 
marker for intercellular MHC transfer between DC and EpCAM+ mTEC or tumor cells in 
vivo (10, 31). Our data demonstrate that in addition to capturing EpCAM, thymic DC 
directly express this glycoprotein, with RNA levels only ~3-fold less than TEC (Fig. 2). 
Consistent with this finding, surface EpCAM is detected on DC in peripheral lymphoid 
organs, such as skin-draining lymph nodes and the spleen (32), neither of which possess 
large numbers of potential donor EpCAM+ stromal cells (33). EpCAM mediates homophilic 
adhesion (34), and therefore may enhance the interaction between EpCAM+ thymic DC and 
mTEC (or other EpCAM+ DC). Indeed, trogocytosis is generally considered to be receptor-
mediated, and thymic DC have been found tethered to TEC in vivo (35). It is intriguing that 
thymic B cells, of which <5% express EpCAM (data not shown), function as poor MHC 
donors (Fig. 1,4). A direct role for EpCAM facilitating and/or enhancing an interaction and 
subsequent MHC transfer between mTEC and thymic DC still needs to be determined. 
Notably, ectopic expression of EpCAM by an epithelial thymic cell line induced cytoskeletal 
and membrane reorganization leading to active membrane exchange (36). Other molecules 
also likely contribute to DC cross-dressing; for instance despite a similar capacity to acquire 
MHC, SIRPα+ cDC express ~2-fold more surface EpCAM than CD8α+ cDC (Fig. 2), and 
EpCAM− thymic DC continue to acquire MHC albeit less efficiently (Fig. 2). MHC 
acquisition by thymic DC, however, was unaffected by Ab blockade of the class A scavenger 
receptor (data not shown), which has been reported to promote intercellular transfer by non-
human primate monocyte-derived DC (37).
Interestingly, recent work by Ardouin et al. demonstrated that the maturation status of 
thymic CD8α+ (XCR1+) cDC impacts the efficacy of cross-presentation of TEC-derived 
self-Ag (38). Here, mature (CCR7+) but not immature (CCR7−) thymic CD8α+ cDC cross-
present a neo-self Ag expressed by TEC (38). In support of this observation, we have found 
that EpCAM expression was increased among mature CCR7+ (>40%) versus immature 
CCR7− (<20%) CD8α+ (XCR1+) cDC residing in the thymus of NOD and B6 mice (data 
not shown). Furthermore, thymic versus splenic CD8α+ and SIRPα+ cDC exhibit a more 
“mature” phenotype which is coupled with increased EpCAM expression and a superior 
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cross-dressing ability (Fig. 2). Variation in maturation and corresponding gene expression 
profiles may further impact other aspects of thymic DC cross-dressing, such as the role of 
PI3K.
A hierarchy in T cell stimulation was also detected among cross-dressing thymic DC 
subsets. Thymic cDC exhibited a greater T cell stimulatory capacity compared to pDC (Fig. 
3). The latter is consistent with reduced MHC acquisition by thymic pDC (Figs. 1,5) in vitro 
and in vivo (27). Cross-dressing thymic CD8α+ cDC exhibited enhanced CD4+ T cell 
stimulation relative to thymic SIRPα+ cDC, despite similar pMHC acquisition, and 
expression of costimulatory molecules. Differences in turnover or stability of acquired 
pMHC may contribute to the increased stimulatory capacity of cross-dressing CD8α+ cDC. 
Thymic CD8α+ cDC acquiring pMHC from mTEC in vivo were found to play a key role in 
the development of Foxp3+Treg specific for Aire-dependent Ag (39). An enhanced 
stimulatory function coupled with an increased frequency may favor cross-dressing thymic 
CD8α+ over SIRPα+ cDC, particularly when specific pMHC are expected to be limiting in 
vivo.
Our findings demonstrate that intercellular MHC transfer is rapid, and requires direct contact 
between TEC and thymic DC (Fig. 4), consistent with the process of trogocytosis. However, 
cell contact alone was insufficient for MHC capture, and that the identity of donor cell was 
critical. Intercellular MHC transfer was readily detected for donor mTEC, less so for DC, 
but not seen for thymic or splenic B cells (Fig. 1). B cell activation and upregulation of 
surface MHC expression only minimally increased DC cross-dressing (Supplemental Fig. 2). 
Despite the lack of MHC transfer, lipid rafts from B cells were efficiently captured by 
thymic DC in a cell contact manner (Fig. 4), indicating efficient plasma membrane 
exchange. The latter suggests an element of selectivity in MHC acquisition by thymic DC. 
These findings also suggest that thymic B cells contribute to negative selection (40) by 
directly functioning as APC and not by “donating” pMHC. Disrupting lipid rafts in donor 
cells had no effect on MHC acquisition by thymic DC (Fig. 4), indicating that lipid rafts do 
not “mark” MHC for capture. Whether the efficiency and/or selectivity of intercellular MHC 
transfer are driven by similar or distinct receptor-ligand interactions (e.g. EpCAM-mediated) 
is a possibility being investigated.
A key observation made in our study is that PI3K signaling was necessary for efficient MHC 
acquisition by thymic DC (Fig. 5). A similar result has been reported for T cells and TCR-
mediated trogocytosis (23). The requirement for PI3K signaling, however, was dependent on 
thymic DC subset. Induced pAKTThr308 levels were detected in thymic pDC and CD8α+ 
cDC following MHC acquisition, which in turn was significantly reduced by inhibiting PI3K 
signaling (Fig. 5). How PI3K signaling is activated and regulates MHC acquisition by 
thymic pDC and CD8α+ cDC needs to be further investigated. Also of keen interest is the 
nature of the signaling event(s) regulating MHC acquisition by thymic SIRPα+ cDC. One 
possible scenario is that constitutively high PI3K signaling, reflected by elevated 
pAKTThr308 levels (Fig. 5), “primes” SIRPα+ cDC for efficient MHC capture. On the other 
hand, due to comparatively low basal levels of pAKTThr308, PI3K signaling must be elevated 
to achieve a given threshold needed for efficient MHC acquisition in thymic pDC and 
CD8α+ cDC. Alternatively, regulation of MHC acquisition by thymic SIRPα+ cDC may be 
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PI3K-independent suggesting that a distinct receptor may contribute to the cross-dressing 
process.
In summary, this study provides evidence that intercellular MHC transfer by thymic DC is 
complex and influenced by a variety of parameters. Our in vitro model system can be 
exploited to further define the mechanisms by which thymic DC acquire MHC and other 
proteins, and in turn refine our understanding of the relative role of DC in central tolerance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Thymic DC acquire MHC class I and II from TEC and DC but not B cells
(A) The design of the in vitro intercellular MHC transfer assay. (B–D) Representative flow 
cytometric plots for IEd and H2Dd acquisition by NOD thymic DC after co-culture with 
BALB/c (B) TEC, (C) thymic or splenic DC, and (D) thymic or splenic B cells. All cells 
were cultured at a 1:2 donor cell to DC ratio. (E) Frequency of IEd+ and H2Dd+ thymic DC 
after co-culture with the different donor cells. (F) IEd and H2Dd staining on the different 
BALB/c donor cell populations. Data is representative of 2–3 experiments.
Kroger et al. Page 13
J Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Thymic versus splenic DC acquire MHC more efficiently, which correlates with DC 
expression of EpCAM
(A) Representative flow cytometric plots of IEd and H2Dd staining of NOD thymic and 
splenic DC co-cultured with BALB/c TEC at a ratio of 1:2. (B) The frequency of IEd+ and 
H2Dd+ and (C) MFI of IEd and H2Dd staining of NOD thymic and splenic DC (250 × 103/
well) after co-culture with varying numbers of BALB/c TEC from a representative 
experiment. (D,E) Data depicting the frequency (D) or MFI (E) pooled from2 separate 
experiments examining the 1:2 cell ratio. *, P< 0.05, Student’s paired t-test. (F,G) 
Representative flow cytometric plots, and the frequency of EpCAM+ cells and MFI of 
EpCAM staining for thymic and splenic DC subsets. Data is the average of 3 mice; *, P< 
0.05, Student’s paired t-test. (H) NOD thymic DC were co-cultured with BALB/c TEC as in 
Fig. 1 and the frequency of IEd+ CD8α+ and SIRPα+ DC determined as a function of time 
and EpCAM expression. Data is representative of 2 independent experiments. */#, P< 0.05, 
2-way ANNOVA test. *CD8α+ DC, #SIRPα+ DC. (I) Representative pre-sort and post-sort 
analysis of EpCAM− and EpCAM+ cDC used for RT-qPCR analysis of Epcam mRNA. Cells 
were gated on Live/CD45+/CD11chi. (J) Relative expression of Epcam by thymic DC 
(normalized to EpCAM− cDC =1). Data are pooled from 3 independent experiments. All 
error bars represent SEM.
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Figure 3. A hierarchy exists among cross-dressed thymic DC for T cell stimulation
(A) Representative flow cytometric analysis (gated on live cells) of pre- and post-FACS 
sorted BALB/c thymic DC (CD11c+ CD45.2+) after 4 h culture with peptide-pulsed NOD 
TEC (CD45.1+) at a ratio of 1:1. (B) Proliferation of CTV-labeled BDC2.5 CD4+ T cells 
stimulated by FACS-sorted thymic DC and TEC. Plots were gated on Live/Thy1.2+/CD4+ 
cells. (C) The average of 3 independent experiments assessing proliferation of CTV-labeled 
BDC2.5 CD4+ T cells as in (B); ± SEM percent proliferated. (D) Individual BALB/c thymic 
DC subsets were sorted after the 4 h co-culture with NOD TEC previously pulsed with 
titrated concentrations of sBDC, and proliferation of CTV labeled BDC2.5 CD4+ T cells 
measured. Representative and pooled data from 3 independent experiments are shown ± 
SEM. */#, P< 0.05, Student’s paired t-test; *CD8α+ DC versus pDC, #SIRPα+ DC versus 
pDC.
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Figure 4. DC acquisition of TEC MHC class II does not require TEC lipid raft integrity and is 
cell contact-dependent
(A,B) NOD thymic DC were purified and co-cultured with CTxB-labeled (A) TEC (1:2 
TEC:DC) or (B) splenic B cells (1:1 B:DC) from BALB/c mice, and DC acquisition of IEd 
and CTxB assessed via flow cytometry. Data are representative of 3 experiments. (C) 
Isolated BALB/c TEC were treated with 10 mM MβCD and then co-cultured with NOD 
thymic DC as in (A). Data are representative of 2 experiments. (D) IEd and CTxB 
acquisition by NOD thymic DC cultured with CTxB-labeled BALB/c TEC at a 2:1 ratio in a 
0.4 μm TransWell. Data are representative of 2–3 experiments. All numbers within plots 
indicate frequency of IEd+ ± SEM.
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Figure 5. A thymic DC subset-specific role for PI3K in MHC class II acquisition
(A) Purified NOD thymic DC were co-cultured with B6 TEC (1:2 TEC:DC) for the 
indicated time point then fixed. The relative level of pAKTThr308 was determined by flow 
cytometry on the respective NOD thymic DC that either did not (IAb−) or did (IAb+) acquire 
TEC MHC. (B) The fold increase in pAKTThr308 levels in NOD DC was determined by 
examining the respective MFI on IAb+ DC versus IAb− DC at the indicated time points. Data 
± SEM are the result of 3 independent experiments. #/*, P< 0.05, Student’s paired t-test for 
CD8α+ and pDC respectively. (C) Representative data of purified NOD thymic DC were 
pre-treated with a titrated concentration of PI3K inhibitor LY29 or DMSO Vehicle (Veh) for 
30–60 min prior to and during their co-culture with BALB/c TEC (1:2 TEC:DC) for 2–3 h, 
and then DC acquisition of IEd measured via flow cytometry. All numbers within plots 
indicate percent IEd+ for the indicated DC subset. (D) The relative IEd acquisition efficiency 
of the respective NOD thymic DC subsets, setting the percent of Vehicle IEd+ DC as 100% 
for each experiment. (E) The relative level of IEd acquired following LY29 treatment, setting 
the Vehicle DC IEd MFI as 100% for each experiment. (C–E) Means ± SEM are pooled 
from at least 4 experiments for each LY29 concentration. *, P< 0.05, Student’s paired t-test.
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